Valuation (53%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 16.60 | 37.14 |
PEG Ratio (TTM) | -0.70 | 3.43 |
P/S Ratio (TTM) | 0.54 | 3.39 |
P/B Ratio (TTM) | 0.70 | 6.58 |
P/FCF Ratio (TTM) | 49.62 | 43.57 |
Price to 5YR AVG Earnings Ratio | 22,809.52 | 80.86 |
Price to 5YR AVG FCF Ratio | 56.70 | 131.10 |
Profitability (18%) |
Company | Industry |
---|---|---|
ROA (TTM) | 3.33% | 6.59% |
ROE (TTM) | 4.25% | 11.65% |
Net Profit Margin (TTM) | 3.25% | 6.47% |
ROIC 5YR AVG | 0.47% | 15.81% |
Growth (20%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -45.85% | -75.84% | -6.75% |
Revenue | 0.34% | 1.56% | -0.65% |
Net Income | -44.95% | -75.58% | -5.81% |
Cash Flow | 44.36% | -12.43% | 37.39% |
Health (63%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 6.39 | 1.27 |
Quick Ratio (TTM) | 1.55 | 0.90 |
D/E Ratio (TTM) | N/A | 1.58 |
Interest Coverage (TTM) | N/A | 16.76 |
Piotroski F-Score | 8 | 7 |
Altman Z-Score | 4.64 | 4.59 |
LTL to 5YR AVG FCF | 8.79 | 18.53 |
Shares Outstanding Growth 5YR AVG | -1.89% | 39.48% |